Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Edge

Showing results (131-140 of 195) with videos related to

Pageof 20
Sort By:
Breast Cancer Research and Treatment|April 30, 2013
Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancersChi-Chen Hong, Song Yao, Susan E McCann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality MeasuresChristopher E Desch, Kristen K McNiff, Eric C Schneider, et al.
Epigenetics|June 2, 2016
DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) studyCatherine L Callahan, Youjin Wang, Catalin Marian, et al.
Cancer Causes & Control : CCC|May 26, 2010
Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) StudyTheodore M Brasky, Matthew R Bonner, Kirsten B Moysich, et al.
Breast Cancer Research and Treatment|August 3, 2010
Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) StudyTheodore M Brasky, Matthew R Bonner, Kirsten B Moysich, et al.
Annals of Surgical Oncology|June 2, 2024
Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01)Laura K Krecko, Heather B Neuman, Caprice C Greenberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2009
DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTRMeng Hua Tao, Peter G Shields, Jing Nie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer SurvivalAnn H Partridge, Melissa E Hughes, Erica T Warner, et al.
Carcinogenesis|May 31, 2011
Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web studyMichelle R Roberts, Peter G Shields, Christine B Ambrosone, et al.
Journal of Pain and Symptom Management|May 31, 2023
ADCC's Improving Goal Concordant Care Initiative: Implementing Primary Palliative Care PrinciplesElizabeth T Loggers, Amy A Case, Marcin Chwistek, et al.
Pageof 20

Showing results (131-140 of 195) with videos related to

Sort By:
Pageof 20
Breast Cancer Research and Treatment|April 30, 2013
Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancersChi-Chen Hong, Song Yao, Susan E McCann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality MeasuresChristopher E Desch, Kristen K McNiff, Eric C Schneider, et al.
Epigenetics|June 2, 2016
DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) studyCatherine L Callahan, Youjin Wang, Catalin Marian, et al.
Cancer Causes & Control : CCC|May 26, 2010
Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) StudyTheodore M Brasky, Matthew R Bonner, Kirsten B Moysich, et al.
Breast Cancer Research and Treatment|August 3, 2010
Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) StudyTheodore M Brasky, Matthew R Bonner, Kirsten B Moysich, et al.
Annals of Surgical Oncology|June 2, 2024
Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01)Laura K Krecko, Heather B Neuman, Caprice C Greenberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2009
DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTRMeng Hua Tao, Peter G Shields, Jing Nie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer SurvivalAnn H Partridge, Melissa E Hughes, Erica T Warner, et al.
Carcinogenesis|May 31, 2011
Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web studyMichelle R Roberts, Peter G Shields, Christine B Ambrosone, et al.
Journal of Pain and Symptom Management|May 31, 2023
ADCC's Improving Goal Concordant Care Initiative: Implementing Primary Palliative Care PrinciplesElizabeth T Loggers, Amy A Case, Marcin Chwistek, et al.
Pageof 20